1.1844
price up icon3.89%   0.0443
after-market 시간 외 거래: 1.17 -0.0144 -1.22%
loading
전일 마감가:
$1.1401
열려 있는:
$1.18
하루 거래량:
5,299
Relative Volume:
0.44
시가총액:
$10.35M
수익:
-
순이익/손실:
-
주가수익비율:
-1.6701
EPS:
-0.7092
순현금흐름:
-
1주 성능:
+2.53%
1개월 성능:
-15.40%
6개월 성능:
-42.22%
1년 성능:
-50.65%
1일 변동 폭
Value
$1.17
$1.19
1주일 범위
Value
$1.10
$1.19
52주 변동 폭
Value
$1.01
$5.41

알테리티 테라퓨틱스 Stock (ATHE) Company Profile

Name
명칭
Alterity Therapeutics Ltd Adr
Name
전화
-
Name
주소
-
Name
직원
10
Name
트위터
@AlterityT
Name
다음 수익 날짜
2024-08-29
Name
최신 SEC 제출 서류
Name
ATHE's Discussions on Twitter

알테리티 테라퓨틱스 주식(ATHE)의 최신 뉴스

pulisher
Oct 15, 2024

Alterity Therapeutics to join Maxim Healthcare Summit - Investing.com

Oct 15, 2024
pulisher
Oct 14, 2024

Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.

Oct 14, 2024
pulisher
Oct 04, 2024

Alterity Therapeutics announces change in share registry - Investing.com

Oct 04, 2024
pulisher
Oct 04, 2024

Alterity Therapeutics announces change in share registry By Investing.com - Investing.com UK

Oct 04, 2024
pulisher
Oct 01, 2024

Opthea Ltd stock soars to 52-week high, hits $4.47 - Investing.com India

Oct 01, 2024
pulisher
Oct 01, 2024

Alterity Therapeutics names new CFO - Investing.com India

Oct 01, 2024
pulisher
Sep 26, 2024

Alterity Therapeutics discloses annual report for 2024 - Investing.com

Sep 26, 2024
pulisher
Jul 19, 2024

Alterity Therapeutics announces regulatory notice filing - Investing.com

Jul 19, 2024
pulisher
Jul 18, 2024

ATHE’s Stock Market Adventure: -14.26% YTD Growth Amidst Volatility - The InvestChronicle

Jul 18, 2024
pulisher
Jul 17, 2024

Alterity reports positive Phase 2 trial interim data - Investing.com

Jul 17, 2024
pulisher
Jul 15, 2024

Alterity Therapeutics announces trading halt - Investing.com

Jul 15, 2024
pulisher
Jul 15, 2024

Alphabet stock cited by TD Cowen amid potential Wiz acquisition - Investing.com

Jul 15, 2024
pulisher
Jul 15, 2024

Alterity Therapeutics announces trading halt By Investing.com - Investing.com

Jul 15, 2024
pulisher
Jul 15, 2024

Avenue Supermarts stock target raised by Nuvama, still a Hold - Investing.com India

Jul 15, 2024
pulisher
Jul 15, 2024

Wolfe Research keeps Peerperform rating on Goldman Sachs stock, notes mixed Q2 earnings - Investing.com India

Jul 15, 2024
pulisher
Jun 17, 2024

RBC Capital sees growth potential in Bowhead Specialty shares - Investing.com

Jun 17, 2024
pulisher
Jun 12, 2024

ATHEAlterity Therapeutics Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Jun 12, 2024
pulisher
Apr 26, 2024

Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners - Stockhead

Apr 26, 2024
pulisher
Feb 15, 2024

Check Up: Aussie biotech Avarax on the verge of peanut allergy cure; and recent ASX health winners - Stockhead

Feb 15, 2024
pulisher
Jan 02, 2024

ASX Health Winners December: Health stocks beat market, look ‘undervalued’ going into 2024 - Stockhead

Jan 02, 2024
pulisher
Nov 20, 2023

Closing Bell: The ASX is slightly higher, but not much cooler on Monday - Stockhead

Nov 20, 2023
pulisher
Aug 17, 2023

Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money ... - Stockhead

Aug 17, 2023
pulisher
Jan 06, 2023

Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation) - PR Newswire

Jan 06, 2023
pulisher
Jul 02, 2021

24 Stocks Moving in Friday's Pre-Market SessionAlterity Therapeutics (NASDAQ:ATHE) - Benzinga

Jul 02, 2021
pulisher
Mar 19, 2020

The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection - Yahoo Finance

Mar 19, 2020
pulisher
Mar 17, 2020

The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Sh - Benzinga

Mar 17, 2020
pulisher
Jan 12, 2020

Check up: Enthusiasm rather than news is moving health stocks - Stockhead

Jan 12, 2020
pulisher
Jan 03, 2020

The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger - Yahoo Finance

Jan 03, 2020
pulisher
Dec 19, 2019

The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For An - Benzinga

Dec 19, 2019
pulisher
Jul 30, 2019

54 Biggest Movers From YesterdayAcasti Pharma (NASDAQ:ACST), Alterity Therapeutics (NASDAQ:ATHE) - Benzinga

Jul 30, 2019

알테리티 테라퓨틱스 (ATHE) 재무 분석

알테리티 테라퓨틱스 (ATHE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):